Articles with public access mandates - Jeffrey V Lazarus - Agence Nationale de la RechercheLearn more
Not available based on mandate: 1
Review
France removes hepatitis C treatment prescriber restrictions—but what is the impact of the delay for key populations?
F Marcellin, P Roux, JV Lazarus, B Rolland, P Carrieri
Liver International 39 (12), 2019
Available based on mandate: 6
Review
Progress towards elimination goals for viral hepatitis
AL Cox, MH El-Sayed, JH Kao, JV Lazarus, M Lemoine, AS Lok, F Zoulim
Nature reviews Gastroenterology & hepatology 17 (9), 533-542, 2020
Review
Patient-reported outcomes to enhance person-centred HIV care
M Kall, F Marcellin, R Harding, JV Lazarus, P Carrieri
The lancet HIV 7 (1), e59-e68, 2020
Review
Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
M Oliu-Barton, BSR Pradelski, Y Algan, MG Baker, A Binagwaho, GJ Dore, ...
The Lancet global health 10 (1), e142-e147, 2022
Review
Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010–19: an analysis of data from a …
R Sacks-Davis, DK van Santen, A Boyd, J Young, A Stewart, JS Doyle, ...
The Lancet HIV 11 (2), e106-e116, 2024
Review
Alcohol use disorder and hepatitis C prevention and care in people who inject drugs: the state of play
F Marcellin, A Jaquet, JV Lazarus, P Molina, P Carrieri
Seminars in liver disease 41 (02), 109-116, 2021
Review
Examining How Young Adults Perceive, Understand, and Respond to SARS-CoV-2 Variants in Canada and France: Implications for Public Health Preparedness Efforts
PJ Coulaud, F Débarre, N Bolduc, D Greyson, JV Lazarus, ...
Disaster Medicine and Public Health Preparedness 17, e462, 2023
Publication and funding information is determined automatically by a computer program